CANB - Canbiola, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0280
+0.0002 (+0.72%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.0278
Open0.0350
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0250 - 0.0350
52 Week Range0.0220 - 0.1350
Volume1,177,195
Avg. Volume1,589,770
Market Cap18.797M
Beta (3Y Monthly)-0.43
PE Ratio (TTM)N/A
EPS (TTM)-0.0140
Earnings DateAug 20, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire

    Canbiola Reports Second Quarter 2019 Results

    Revenue Increased by 311% Closed $3.9 Million Equity Raise Completed HICKSVILLE, N.Y., Aug. 20, 2019 -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a.

  • GlobeNewswire

    Canbiola Launches Dedicated Canbiola-Branded CBD Dispensing Machine

    Initial 25 Units Will Target Medical Offices HICKSVILLE, NY, Aug. 05, 2019 -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer,.

  • GlobeNewswire

    Canbiola Appoints John Bach to its Corporate Advisory Board

    HICKSVILLE, NY, July 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer, and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate, announced today the appointment of John Bach to its Corporate Advisory Board. CanbiolaChief Executive Officer Marco Alfonsi commented, “We are pleased to welcome John to our team, as the newest member of our Corporate Advisory Board. John brings over 40 years of relationships and experience, especially in mergers and acquisitions and the legal and structural sides of transactions.

  • GlobeNewswire

    Canbiola Names Johnny J. Mack as Interim Chief Operating Officer and Director

    HICKSVILLE, NY, July 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer, and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate is pleased to announce the appointment of Johnny J Mack Ph.D. as its interim Chief Operating Officer and Director. Canbiola Chief Executive Officer Marco Alfonsi commented, “While we have worked with Johnny in an advisory role for the past several months, we are thrilled to formally add him to our executive team and Board of Directors. Mr. Mack stated, “I am proud to officially join the executive team and Board of Directors of Canbiola.

  • GlobeNewswire

    Canbiola Becomes Vertically Integrated with its Joint Venture with NY SHI and Shi Farms

    HICKSVILLE, NY, July 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer, and seller of a variety of Cannabidiol (Hemp)-based products, such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate, announced today that it and its wholly-owned subsidiary, NY Hemp Depot LLC, have officially formed a joint venture with NY – SHI, LLC (“NY – SHI”) and EWSD I LLC dba Shi Farms (“Shi Farms”), a proven existing hemp grow and processing company, to aggregate and purchase fully-grown, harvested industrial hemp from third-party farmers in the State of New York. The joint venture will operate the NY Hemp Depot Facility for hemp processing in the State of New York.

  • ACCESSWIRE

    Canbiola, Inc. Joins the Stock Day Podcast Introducing Dr. Johnny J. Mack PhD as the New COO and Director and Closing the Shi Farms JV

    PHOENIX, AZ / ACCESSWIRE / July 22, 2019 / The Stock Day Podcast welcomed Canbiola, Inc. (CANB) (“the Company”), a developer, manufacturer, and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate gel caps, and concentrates. Chairman and CEO, Marco Alfonsi, joined Stock Day host Everett Jolly. Alfonsi opened the interview by announcing that Dr. Johnny J. Mack, Ph.D., will be joining the management team of the Company as their new COO and member of the Board of Directors.

  • GlobeNewswire

    Canbiola Presentation from Annual Shareholder Meeting is Publicly Available

    Provides Details on Growth Strategy HICKSVILLE, NY, July 02, 2019 -- via NEWMEDIAWIRE -- Canbiola,Inc. (OTCQB: CANB)(“Canbiola” or the “Company”), a developer,.

  • GlobeNewswire

    Canbiola and Shi Farms Execute Letter of Intent to Form Joint Venture for Hemp Cultivation & Processing

    Plans to Open a NY Depot for Hemp Cultivation HICKSVILLE, NY, June 12, 2019 -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the.

  • GlobeNewswire

    Canbiola Sets Annual Shareholder Meeting for Friday, June 14

    At Melville Marriott, Long Island Hotel from 10 am to 1 pm ET HICKSVILLE, NY, May 29, 2019 -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the.

  • GlobeNewswire

    Canbiola Announces First Quarter 2019 Results 

    Quarterly Revenue Increased 741% and Almost Matching Entire Year 2018; Revenue Maintained Gross Margin of 49% HICKSVILLE, NY, May 28, 2019 -- via NEWMEDIAWIRE.

  • Newsfile

    Canbiola Announces First Quarter 2019 Results

    Quarterly Revenue Increased 741% and Almost Matching Entire Year 2018; Revenue Maintained Gross Margin of 49% Hicksville, New York--(Newsfile Corp. - May 28, 2019) - Canbiola, Inc. (OTCQB: CANB) ("Canbiola" or the "Company"), a developer, manufacturer and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate, announced today operating and financial results for the first quarter ended March 31, 2019. "I am pleased ...

  • GlobeNewswire

    Canbiola Appoints David Woycik, Jr. to its Corporate Advisory Board and Completes a 300% Increased Investment in its Duramed Division to Combat the Opioid Crisis

    Canbiola Chief Executive Officer, Marco Alfonsi, commented, “We are thrilled to have Mr. Woycik join our Corporate Advisory Board. Mr. David Woycik, Jr. stated, “I am extremely proud and honored to become a member of Canbiola’s Corporate Advisory Board. As the former Vice President and General Counsel of a major pharmaceutical company, PharmaFair, Inc., I fully appreciate the need for experienced and knowledgeable business men and women to assist this new and exciting company for greater success in the future.

  • ACCESSWIRE

    Canadabis Capital Resumes Trading and Launches Corporate Website

    CALGARY, AB / ACCESSWIRE / April 30, 2019 / CanadaBis Capital Inc.("CanadaBis or the Company") is pleased to announce that it will begin trading as a Tier 2 Life Sciences Issuer on April 30th, 2019 under the symbol CANB and that it has officially launched its new corporate website, which is now available at www.canadabis.com. The new website will showcase the Company's products and services, as well as provide shareholders and potential investors a better understanding of CanadaBis's vision for the future. CanadaBis, through its subsidiaries, will operate the business of Stigma Grow and continue to be focused on producing high-quality and uniquely crafted products for the Alberta market.

  • CNW Group

    IIROC Trading Resumption - CANB

    IIROC Trading Resumption - CANB

  • ACCESSWIRE

    Uptick Newswire Hosts Canbiola, Inc. on the Stock Day Podcast to Discuss Their 500% Revenue Increase Since 2017

    PHOENIX, AZ / ACCESSWIRE / April 22, 2019 / Uptick Newswire Stock Day Podcast welcomed Canbiola, Inc. (CANB) ("the Company"), a US Company embarking in the sale of a variety of Cannabidiol (CBD) based products. CFO, Stan Teeple, joined Stock Day host Everett Jolly. Jolly began the interview by congratulating Teeple on the Company's substantial growth, which is reflected by their 500% revenue increase since 2017.

  • GlobeNewswire

    Canbiola Announces Fourth Quarter and Full Year 2018 Results

    Annual Revenue Increased 445%, Maintained Gross Margin of 50% HICKSVILLE, NY, April 17, 2019 -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the.

  • GlobeNewswire

    Canbiola Appoints Additional Members to its Corporate Advisory Board

    HICKSVILLE, NY, March 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate, announced today the appointments of Mr. Jason Winn and Dr. Mehran Peter Ghazvini to its Corporate Advisory Board. Both have been active proponents for chronic pain management and tissue healing solutions. Canbiola Chief Executive Officer, Marco Alfonsi, commented, “We are pleased to have both Mr. Winn and Dr. Ghazvini join our Corporate Advisory Board.

  • ACCESSWIRE

    Uptick Newswire Hosts Canbiola, Inc. on The Stock Day Podcast to Discuss Growth Potential in 2019

    PHOENIX, AZ / ACCESSWIRE / March 18, 2019 / Uptick Newswire Stock Day Podcast welcomed Canbiola, Inc.(CANB) (''the Company''), a US Company embarking in the sale of a variety of Cannabidiol (CBD) based products. Executive Vice President of Domestic and International Sales, Andrew W. Holtmeyer, joined Stock Day host Everett Jolly.

  • GlobeNewswire

    Marathon Group's Wholly Owned Subsidiary, MarathonRx, Secures 1st Large Order; 3 Product Lines Now Available

    WATERBURY, CT, March 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Marathon Group Corp. (PDPR) (the “Company” or “Marathon”) wholly owned subsidiary, MarathonRx, has signed their 1st order and expands product line to include previously mentioned 1,500mg Nano-Pure Ultra CBD Drops along with new products Tasty Drops 4 Pets and Muscle & Joint Salve. MarathonRx reviewed many companies to secure top quality products for their clients. Pure Health Product LLC, owned by Canbiola, Inc. (CANB), was chosen because they maintain a high level of quality throughout the manufacturing process, use organic ingredients wherever possible and/or naturally derived ingredients otherwise.

  • GlobeNewswire

    Canbiola is Registered and Active in the GSA’s System for Award Management (SAM) and Department of Defense (DOD)

    HICKSVILLE, NY, March 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer, manufacturer and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate, announced today that it is now registered and active in the U.S. government GSA’s System for Award Management (SAM) and Department of Defense (DOD). The System for Award Management (SAM) is an official website of the U.S. government. GSA’s Office of Government-wide Policy is consolidating federal procurement and award systems into 1 new system—the System for Award Management (SAM).

  • Newsfile

    Canbiola Finalizes Asset Purchase Agreement with Seven Chakras

    Attains Proprietary CBD Formulations Hicksville, New York--(Newsfile Corp. - February 28, 2019) - Canbiola, Inc. (OTCQB: CANB) ("Canbiola" or the "Company"), a developer, manufacturer and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, vapes, isolate, gel caps and concentrate, announced today that its wholly owned subsidiary Pure Health Products (PHP) finalized its asset purchase agreement (APA) with Seven Chakras, LLC. Under the terms of this APA, which ...

  • GlobeNewswire

    Canbiola Finalizes Asset Purchase Agreement with Seven Chakras.

    Attains Proprietary CBD Formulations HICKSVILLE, NY, Feb. 27, 2019 -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) (“Canbiola” or the “Company”), a developer,.

  • Newsfile

    Canbiola Deploys Initial 100 sam(R) Units and Readies Next 100 sam(R) Units

    Revolutionary CBD Wellness Solution for Tissue Healing and Chronic Pain is Now in the Hands of 100 Medical Professionals Hicksville, New York--(Newsfile Corp. - February 21, 2019) -  Canbiola, Inc. (OTCQB: CANB) ("Canbiola" or the "Company"), a developer, manufacturer and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, vapes, isolate, gel caps and concentrate, announced today that its initial 100 Sustained Acoustic Medicine ("sam®") units have been deployed ...

  • GlobeNewswire

    Canbiola Deploys Initial 100 sam® Units and Readies Next 100 sam® Units

    Revolutionary CBD Wellness Solution for Tissue Healing and Chronic Pain is Now in the Hands of 100 Medical Professionals HICKSVILLE, NY, Feb. 21, 2019 -- via NEWMEDIAWIRE.

  • GlobeNewswire

    Canbiola to Exhibit at Integrative Healthcare Symposium and Engages Hayden IR to Launch Comprehensive Investor Relations Program

    Industry Tradeshow on February 21-23 at New York Hilton Midtown New York Focused on Increasing Awareness and Enhancing Shareholder Value HICKSVILLE, NY, Feb. 20, 2019 --.